Enliven Therapeutics, Inc. (ELVN)

Enliven Therapeutics Statistics

Total Valuation

ELVN has a market cap or net worth of $1.18 billion. The enterprise value is $694.79 million.

Market Cap	1.18B
Enterprise Value	694.79M

Important Dates

The next estimated earnings date is Friday, November 7, 2025, after market close.

Earnings Date	Nov 7, 2025
Ex-Dividend Date	n/a

Share Statistics

ELVN has 59.24 million shares outstanding. The number of shares has increased by 16.08% in one year.

Current Share Class	59.24M
Shares Outstanding	59.24M
Shares Change (YoY)	+16.08%
Shares Change (QoQ)	+4.10%
Owned by Insiders (%)	4.16%
Owned by Institutions (%)	67.32%
Float	36.38M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	2.42
P/TBV Ratio	2.43
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 32.58, with a Debt / Equity ratio of 0.00.

Current Ratio	32.58
Quick Ratio	32.25
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -25.26% and return on invested capital (ROIC) is -17.98%.

Return on Equity (ROE)	-25.26%
Return on Assets (ROA)	-17.19%
Return on Invested Capital (ROIC)	-17.98%
Return on Capital Employed (ROCE)	-23.38%
Revenue Per Employee	n/a
Profits Per Employee	-$1.62M
Employee Count	62
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -31.60% in the last 52 weeks. The beta is 1.04, so ELVN's price volatility has been similar to the market average.

Beta (5Y)	1.04
52-Week Price Change	-31.60%
50-Day Moving Average	20.39
200-Day Moving Average	20.15
Relative Strength Index (RSI)	40.55
Average Volume (20 Days)	517,742

Short Selling Information

The latest short interest is 6.42 million, so 10.84% of the outstanding shares have been sold short.

Short Interest	6.42M
Short Previous Month	5.70M
Short % of Shares Out	10.84%
Short % of Float	17.65%
Short Ratio (days to cover)	11.45

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-114.24M
Pretax Income	-100.22M
Net Income	-100.22M
EBITDA	-113.93M
EBIT	-114.24M
Earnings Per Share (EPS)	-$2.00

Balance Sheet

The company has $490.50 million in cash and $580,000 in debt, giving a net cash position of $489.92 million or $8.27 per share.

Cash & Cash Equivalents	490.50M
Total Debt	580,000
Net Cash	489.92M
Net Cash Per Share	$8.27
Equity (Book Value)	488.47M
Book Value Per Share	8.25
Working Capital	480.41M

Cash Flow

In the last 12 months, operating cash flow was -$70.58 million and capital expenditures -$181,000, giving a free cash flow of -$70.76 million.

Operating Cash Flow	-70.58M
Capital Expenditures	-181,000
Free Cash Flow	-70.76M
FCF Per Share	-$1.19

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ELVN does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-16.08%
Shareholder Yield	-16.08%
Earnings Yield	-8.46%
FCF Yield	-5.97%

Analyst Forecast

The average price target for ELVN is $41.20, which is 106.00% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$41.20
Price Target Difference	106.00%
Analyst Consensus	Strong Buy
Analyst Count	5
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-5.20%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2